New study determines cystic fibrosis therapy is safe and effective for young children

Children ages two to five who have the most common form of cystic fibrosis (CF), caused by two copies of the F508 gene mutation, have not had any modulator treatments available to them until recently. A new study authored by researchers at Children’s Hospital Colorado and published May 6, 2021, in Lancet Respiratory Medicine shows …

Exercise can help support recovery of patients with lasting COVID symptoms, study finds

Patients with lasting symptoms of COVID-19 who completed a six-week, supervised rehabilitation program demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre—a partnership between Leicester’s Hospitals, the University of Leicester and Loughborough University.